FDA Inspection 1180123 — Innovative Blood Resources, A Division Of New York Blood Center, Inc.
The FDA completed an inspection of Innovative Blood Resources, A Division Of New York Blood Center, Inc. on Sep 1, 2022 in Minneapolis, MN. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 1, 2022
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Minneapolis, MN (United States)